Intrinsic Value of S&P & Nasdaq Contact Us

Intercept Pharmaceuticals, Inc. ICPT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
62/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$22.11
+16.4%

Intercept Pharmaceuticals, Inc. (ICPT) has 20 known insider and institutional holders on record. The largest holder is Genextra S.p.A. with 5,417,000 shares. Other notable holders include Micheli Francesco and Pruzanski Mark.

ICPT Insider Ownership

Top Holder
Genextra S.p.A.
5,417,000 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Genextra S.p.a. 10 Percent Owner 5,417,000 2020-08-17
100%
2 Micheli Francesco 10 Percent Owner 5,417,000 2020-08-17
100%
3 Pruzanski Mark Director 618,894 2021-12-02
11%
4 Durso Jerome Benedict President & CEO 82,700 2023-01-31
2%
5 Berrey M Michelle President, R&d & CMO 80,139 2023-09-18
1%
6 Saik Andrew EVP & Chief Financial Officer 68,265 2023-09-25
1%
7 Freedberg Jared General Counsel 56,443 2023-11-03
1%
8 Richardson Linda M EVP & Chief Commercial Officer 43,291 2023-02-16
1%
9 Cawkwell Gail SVP, Med Affairs, Safety & Pv 35,740 2022-02-15
1%
10 Duncan Barbara Gayle Chief Accounting Officer 30,661 2016-10-05
1%
11 Weyer Christian EVP, Research & Development 27,341 2021-04-05
1%
12 Kapadia Sandip CFO and Treasurer 26,900 2021-01-26
0%
13 Ball Bryan Chief Qual. Officer & SVP Ops. 25,178 2022-07-13
0%
14 Sullivan Ryan T General Counsel and Secretary 24,708 2020-11-16
0%
15 Bright Lisa President, International 22,012 2020-07-06
0%
16 Kim Richard J President Us Comm & Strat Mktg 20,029 2021-01-05
0%
17 Campagna Jason Chief Medical Officer 19,700 2021-01-26
0%
18 Mcminn Rachel Chief Strategy Officer 16,875 2017-10-04
0%
19 Venezia Rocco Chief Accounting Officer 16,000 2023-01-31
0%
20 Ford David A Chief Human Resources Officer 16,000 2023-01-31
0%

No ownership data available for ICPT.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message